See also this year's filing and all EDGAR filings for this company.
PDF Report 0001175505_2019_FIVE_PRIME_THERAPEUTICS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001175505')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001175505, FIVE PRIME THERAPEUTICS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 288,568,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 28,718,000 |
| 3 | remainder_Assets | 4,248,000 |
| 4 | LiabilitiesCurrent | 27,487,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 39,671,000 |
| 9 | ResearchAndDevelopmentExpense | 156,352,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 49,868,000 |
| 12 | remainder_NetIncome | 5,708,000 |
| 13 | remainder_ComprehensiveNetIncome | 370,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 321,534,000 |
| 1 | Liabilities | 27,487,000 |
| 2 | Expenses | 196,023,000 |
| 3 | Revenues | 49,868,000 |
| 4 | StockholdersEquity | 294,047,000 |
| 5 | NetIncome | -140,447,000 |
| 6 | ComprehensiveNetIncome | -140,262,000 |
| 7 | BaseVar | 300,495,000 |
| 8 | EconomicCapitalRatio | 2.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
